Safety and Efficacy of GABAergic Medications for Treating Alcoholism

Authors

  • Bankole A. Johnson,

    Corresponding author
    1. Departments of Psychiatric Medicine and Neuroscience (BAJ), The University of Virginia, Charlottesville, Virginia; Department of Psychiatry and Human Behavior (RMS), Brown University Medical School, and Research and Education, VA Medical Center, Providence, Rhode Island; Department of Medicine (GA), Institute of Internal Medicine, Catholic University of Rome, Rome, Italy; Division of Psychiatry (DAC), Boston University School of Medicine, Boston, Massachusetts; and Department of Psychiatry (HM), Medical University of South Carolina, Charleston, South Carolina
    Search for more papers by this author
  • Robert M. Swift,

    1. Departments of Psychiatric Medicine and Neuroscience (BAJ), The University of Virginia, Charlottesville, Virginia; Department of Psychiatry and Human Behavior (RMS), Brown University Medical School, and Research and Education, VA Medical Center, Providence, Rhode Island; Department of Medicine (GA), Institute of Internal Medicine, Catholic University of Rome, Rome, Italy; Division of Psychiatry (DAC), Boston University School of Medicine, Boston, Massachusetts; and Department of Psychiatry (HM), Medical University of South Carolina, Charleston, South Carolina
    Search for more papers by this author
  • Giovanni Addolorato,

    1. Departments of Psychiatric Medicine and Neuroscience (BAJ), The University of Virginia, Charlottesville, Virginia; Department of Psychiatry and Human Behavior (RMS), Brown University Medical School, and Research and Education, VA Medical Center, Providence, Rhode Island; Department of Medicine (GA), Institute of Internal Medicine, Catholic University of Rome, Rome, Italy; Division of Psychiatry (DAC), Boston University School of Medicine, Boston, Massachusetts; and Department of Psychiatry (HM), Medical University of South Carolina, Charleston, South Carolina
    Search for more papers by this author
  • Domenic A. Ciraulo,

    1. Departments of Psychiatric Medicine and Neuroscience (BAJ), The University of Virginia, Charlottesville, Virginia; Department of Psychiatry and Human Behavior (RMS), Brown University Medical School, and Research and Education, VA Medical Center, Providence, Rhode Island; Department of Medicine (GA), Institute of Internal Medicine, Catholic University of Rome, Rome, Italy; Division of Psychiatry (DAC), Boston University School of Medicine, Boston, Massachusetts; and Department of Psychiatry (HM), Medical University of South Carolina, Charleston, South Carolina
    Search for more papers by this author
  • Hugh Myrick

    1. Departments of Psychiatric Medicine and Neuroscience (BAJ), The University of Virginia, Charlottesville, Virginia; Department of Psychiatry and Human Behavior (RMS), Brown University Medical School, and Research and Education, VA Medical Center, Providence, Rhode Island; Department of Medicine (GA), Institute of Internal Medicine, Catholic University of Rome, Rome, Italy; Division of Psychiatry (DAC), Boston University School of Medicine, Boston, Massachusetts; and Department of Psychiatry (HM), Medical University of South Carolina, Charleston, South Carolina
    Search for more papers by this author

Reprint requests: Bankole A. Johnson, DSc, MD, Department of Psychiatric Medicine, University of Virginia, P.O. Box 800623, Charlottesville, VA 22908-0623; Fax: 434-982-1853; e-mail: bankolejohnson@virginia.edu.

Abstract

This article highlights the proceedings of a symposium presented at the 27th Annual Scientific Meeting of the Research Society on Alcoholism in Vancouver, British Columbia, Canada, June 29, 2004. The organizers and co-chairs were Bankole A. Johnson, MD, PhD, and Robert M. Swift, MD, PhD. The presentations included (1) Introduction, by Bankole A. Johnson; (2) Safety, Tolerability, and Efficacy of γ-Hydroxybutyric Acid and Baclofen in the Treatment of Alcohol Addiction, by Giovanni Addolorato; (3) Safety of Gabapentin in Treating Alcoholism, by Hugh Myrick; (4) New Data on the Safety and Effectiveness of Topiramate in the Treatment of Alcohol Dependence, by Bankole A. Johnson; (5) Evaluating the Risk of Benzodiazepine Prescription to Alcohol-Dependent Individuals, by Domenic A. Ciraulo; and (6) Safety and Efficacy of GABAergic Agents in Treating Alcoholics: Discussion, by Robert M. Swift.

Ancillary